PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1991 August; 84(8): 451–453.
PMCID: PMC1293369

Does malaria select for predisposition to autoimmune disease?

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (708K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Greenwood BM. Autoimmune disease and parasitic infections in Nigerians. Lancet. 1968 Aug 17;2(7564):380–382. [PubMed]
  • Greenwood BM, Voller A. Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. I. (NZBxNZW) F1 hybrid mice. Clin Exp Immunol. 1970 Dec;7(6):793–803. [PubMed]
  • Greenwood BM, Herrick EM, Voller A. Suppression of autoimmune disease in NZB and (NZB x NZW) F1 hybrid mice by infection with malaria. Nature. 1970 Apr 18;226(5242):266–267. [PubMed]
  • Butcher GA, Clark IA. SLE and malaria: another look at an old idea. Parasitol Today. 1990 Aug;6(8):259–261. [PubMed]
  • Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1990 Feb;87(3):1233–1237. [PubMed]
  • Smolen JS, Chused TM, Leiserson WM, Reeves JP, Alling D, Steinberg AD. Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Correlation with clinical features. Am J Med. 1982 May;72(5):783–790. [PubMed]
  • Jacob CO, McDevitt HO. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature. 1988 Jan 28;331(6154):356–358. [PubMed]
  • Satoh J, Seino H, Shintani S, Tanaka S, Ohteki T, Masuda T, Nobunaga T, Toyota T. Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha. J Immunol. 1990 Sep 1;145(5):1395–1399. [PubMed]
  • Clark IA, Chaudhri G, Cowden WB. Roles of tumour necrosis factor in the illness and pathology of malaria. Trans R Soc Trop Med Hyg. 1989 Jul-Aug;83(4):436–440. [PubMed]
  • Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990 Nov 17;336(8725):1201–1204. [PubMed]
  • Taverne J, Bate CA, Sarkar DA, Meager A, Rook GA, Playfair JH. Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol. 1990 Jan;12(1):33–43. [PubMed]
  • Clark IA. Cell-mediated immunity in protection and pathology of malaria. Parasitol Today. 1987 Oct;3(10):300–305. [PubMed]
  • Greenwood BM, Voller A, Herrick EM. Suppression of adjuvant arthritis by infection with a strain of the rodent malaria parasite Plasmodium berghei. Ann Rheum Dis. 1970 May;29(3):321–323. [PMC free article] [PubMed]
  • Watkinson M, Rushton DI. Plasmodial pigmentation of placenta and outcome of pregnancy in West African mothers. Br Med J (Clin Res Ed) 1983 Jul 23;287(6387):251–254. [PMC free article] [PubMed]
  • McGregor IA. Epidemiology, malaria and pregnancy. Am J Trop Med Hyg. 1984 Jul;33(4):517–525. [PubMed]
  • BRUCE-CHWATT LJ. A LONGITUDINAL LONGITUDINAL SURVEY OF NATURAL MALARIA INFECTION IN A GROUP OF WEST AFRICAN ADULTS. I. West Afr Med J. 1963 Aug;12:141–173. [PubMed]
  • Peyron F, Vuillez JP, Barbe G, Boudin C, Picot S, Ambroise-Thomas P. Plasma levels of tumor necrosis factor during a longitudinal survey in an endemic area of malaria. Acta Trop. 1990 Jan;47(1):47–51. [PubMed]
  • Gordon C, Wofsy D. Effects of recombinant murine tumor necrosis factor-alpha on immune function. J Immunol. 1990 Mar 1;144(5):1753–1758. [PubMed]
  • Butcher GA. In vitro responses of human peripheral blood mononuclear cells to Plasmodium falciparum antigen. Int J Parasitol. 1990 Apr;20(2):211–216. [PubMed]
  • Butcher GA. Mechanisms of immunity to malaria and the possibilities of a blood-stage vaccine: a critical appraisal. Parasitology. 1989 Apr;98(Pt 2):315–327. [PubMed]
  • Taverne J, Bate CA, Playfair JH. Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody. Immunol Lett. 1990 Aug;25(1-3):207–212. [PubMed]
  • Brown AE, Webster HK, Teja-Isavadharm P, Keeratithakul D. Macrophage activation in falciparum malaria as measured by neopterin and interferon-gamma. Clin Exp Immunol. 1990 Oct;82(1):97–101. [PubMed]
  • te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor CG. Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood. 1990 Oct 1;76(7):1392–1397. [PubMed]
  • Troye-Blomberg M, Riley EM, Kabilan L, Holmberg M, Perlmann H, Andersson U, Heusser CH, Perlmann P. Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5484–5488. [PubMed]
  • CORELLI F. Malarial therapy in Buerger's disease. Med World. 1959 Dec;91:529–539. [PubMed]
  • Yamada Y, Kimball K, Okusawa S, Vachino G, Margolis N, Sohn JW, Li JJ, Wakabayashi G, McAdam K, Burke JF, et al. Cytokines, acute phase proteins, and tissue injury. C-reactive protein opsonizes dead cells for debridement and stimulates cytokine production. Ann N Y Acad Sci. 1990;587:351–361. [PubMed]
  • Sinha AA, Lopez MT, McDevitt HO. Autoimmune diseases: the failure of self tolerance. Science. 1990 Jun 15;248(4961):1380–1388. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press